drugset / Trial / NCT05581485

Dex vs SLNB in Spontaneous Breathing Via THRIVE for Laryngeal Surgery

NCT05581485 ↗

Completed 46 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupSingle-blindTreatment

Summary

This prospective, randomized controlled trial evaluated the efficacy and safety of two anesthetic strategies-dexmedetomidine infusion and ultrasound-guided superior laryngeal nerve block (SLNB)-in patients undergoing non-intubated endoscopic laryngeal surgery under spontaneous breathing supported by Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE). The primary outcome was the arterial partial pressure of carbon dioxide (PaCO₂), measured at three time points: before oxygenation, at the end of surgery, and in the post-anesthesia care unit (PACU). Secondary outcomes included other arterial blood gas parameters, hemodynamic variables, and surgeon satisfaction scores.

Timeline

Start
2022-11-29
Primary completion
2025-07-31
Completion
2025-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous

Indications